FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiosurgery and concerns prevention of cardiac rhythm disturbance in coronary bypass. That is ensured by preoperative and postoperative oral introduction of an antiarrhythmic preparation Lappaconitine hydrobromide (Allapinin) with underlying conventional therapy. The preoperative introduction is dosed 25 mg 3 times a day for 7-8 days, while postoperative - for 14 days in dosage 37.5 mg 3 times a day.
EFFECT: introduction of Allapinin in the specified regimen and dosage reduces frequency of postoperative tachyarrythmia after coronary bypass.
1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING ATRIAL FIBRILLATION IN CASE OF MYOCARDIAL INFARCTION | 2005 |
|
RU2268713C1 |
| METHOD FOR SELECTION OF MOST EFFECTIVE ANTIARRHYTHMIC DRUG FOR PATIENTS WITH EXTRASISTOLY | 2017 |
|
RU2641164C1 |
| METHOD FOR SELECTING AN EFFECTIVE ANTIARRHYTHMIC AGENT FOR PATIENTS WITH PREMATURE HEART BEATS | 2019 |
|
RU2707261C1 |
| METHOD FOR PREDICTION OF DURATION OF PRESERVATION OF POSITIVE EFFECT OF PHARMACOLOGICAL ANTIARRHYTHMIC THERAPY IN PATIENTS WITH EXTRASYSTOLIA | 2020 |
|
RU2749851C1 |
| METHOD OF PREDICTING THE EFFECTIVENESS OF THE PHARMACOLOGICAL ANTIARRHYTHMIC THERAPY AS PRIMARY PREVENTION OF ATRIAL FIBRILLATION IN THE PATIENTS WITH ATRIAL EXTRASYSTOLE | 2018 |
|
RU2688394C1 |
| METHOD OF ESTIMATING EFFICIENCY OF ANTI-ARRHYTHMIA THERAPY | 2011 |
|
RU2492483C2 |
| METHOD FOR SELECTING TREATMENT TACTICS FOR TREATING PATIENTS FOR MYOCARDIAL INFARCTION AGGRAVATED WITH VENTRICULAR RHYTHM DISORDERS | 2004 |
|
RU2267984C1 |
| PHARMACEUTICAL COMBINATION FOR PREVENTION AND TREATMENT OF CHRONIC DISORDERS OF VEGETATIVE REGULATION OF HEART RHYTHM AND METHOD OF PREVENTION AND TREATMENT BY MEANS OF PHARMACEUTICAL COMBINATION | 2012 |
|
RU2493836C1 |
| METHOD FOR PREVENTION OF ATRIAL FIBRILLATION IN OPEN LUNG SURGERIES OF ONCOLOGY DISEASES | 2014 |
|
RU2574187C1 |
| ANTI-ARRHYTHMIC PREPARATION | 2002 |
|
RU2223759C1 |
